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Abstract 
Guava Psidium guajava L. (Myrtaceae) budding leaf extract (PE) has 
shown tremendous bioactivities. Previously, we found seven major 
compounds in PE, i.e., gallic acid, catechin, epicatechin, rutin, quercetin, 
naringenin, and kaempferol. PE showed a potentially active antiglycative 
effect in an LDL (low density lipoprotein) mimic biomodel, which can be 
attributed to its large content of polyphenolics. The glycation and 
antiglycative reactions showed characteristic distinct four-phase kinetic 
patterns. In the presence of PE, the kinetic coefficients were 0.000438, 
0.000060, 0.000, and -0.0001354 ABS-mL/mg-min, respectively, for 
phases 1 to 4. Computer simulation evidenced the dose-dependent 
inhibition model. Conclusively, PE contains a large amount of 
polyphenolics, whose antiglycative bioactivity fits the inhibition model. 
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